Gene: GNAO1
Official Full Name: G protein subunit alpha o1provided by HGNC
Gene Summary: The protein encoded by this gene represents the alpha subunit of the Go heterotrimeric G-protein signal-transducing complex. Defects in this gene are a cause of early-onset epileptic encephalopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08744 | GNAO1 Knockout cell line (HeLa) | Human | GNAO1 | 1:3~1:6 | Negative | Online Inquiry |
KO08745 | GNAO1 Knockout cell line (HEK293) | Human | GNAO1 | 1:3~1:6 | Negative | Online Inquiry |
GNAO1 Gene Knockout Cell Lines are specialized cellular models that have been engineered to lack the GNAO1 gene, which encodes for the Gαo subunit of heterotrimeric G proteins. This gene plays a critical role in various signaling pathways, influencing neuronal function, synaptic transmission, and other essential cellular processes. By systematically knocking out GNAO1, researchers are able to investigate the gene's contribution to physiological and pathological conditions, particularly in neurodevelopmental and psychiatric disorders.
Functionally, GNAO1 knockout cell lines facilitate the dissection of G protein-coupled receptor (GPCR) signaling cascades. The absence of GNAO1 helps delineate its specific roles in mediating signal transduction and cellular responses, thus providing insights into alternative signaling pathways that may compensate or be disrupted. The versatility of these cell lines allows for a range of experimental applications, including drug screening, functional assays, and mechanistic studies aimed at understanding disease models.
Scientifically, GNAO1 Gene Knockout Cell Lines are indispensable for researchers studying disorders such as epilepsy, developmental delays, and other genetic conditions associated with GNAO1 mutations. They offer unique advantages over traditional models, such as the ability to conduct high-throughput screenings and more refined manipulation of cellular environments without the confounding effects of a functional GNAO1 gene.
The value of these knockout cell lines extends to both academic and clinical researchers who are seeking novel targets for therapeutic intervention or wanting to translate basic research findings into potential clinical applications. This product empowers users to deepen their understanding of Gαo-related mechanisms and develop innovative strategies for addressing GNAO1-related conditions.
Our company is dedicated to delivering precision biological tools and solutions that leverage state-of-the-art gene-editing technologies. With a focus on quality and reliability, our GNAO1 Gene Knockout Cell Lines exemplify our commitment to advancing research and enabling breakthroughs in the understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.